Weekly CEO & CFO Moves (Dec 15)

by | Dec 15, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of the CEO moves and CFO moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Weekly CEO & CFO Move Wrap

L3Harris Stock Price & Events Graph

Michelle Turner steps aside as L3Harris (NYSE: LHX) CFO as Ken Bedingfield steps in. Ms. Turner came in after LHX’s most recent recovery from a stock price dip during the pandemic, but has seen the stock drop ~4% over her nearly 2 years there (-2.3% annualized). Since hitting an all-time high in March of 2022, LHX has been on a relatively steady decline. However, LHX surged in the past month to over $200 and investors will be wondering whether the new executive team (CEO Kubasik is only 2.5 years on the job) can make the turnaround stick. In part, investors will be bolstered by the recent cooperation agreement with D.E. Shaw that put Kirk Hachigian and William Swanson on the board effective as of the start of December.

CEO Moves

VERADIGM INC (MDRX)
Leaving: CEO – Richard J Poulton ( 1.6 yrs ; -31.7% TSR)
Replaced by (interim)Shih Yin Ho
Dr. Ho, age 53, is a seasoned digital health, software, and pharmaceutical services entrepreneur, executive, and advisor, having spent over 20 years developing products and companies in health information infrastructure, data analytics, and decision support for life sciences. Dr. Ho has served as President of Glimpse LLC (“Glimpse”), an independent software and strategy consulting firm for pharmac…read full bio

CFO Moves

L3HARRIS TECHNOLOGIES INC (LHX)
Leaving: CFO – Michelle L. Turner ( 1.9 yrs ; -2.3% TSR)
Replaced by: Kenneth L Bedingfield
Mr. Bedingfield, 51, joins L3Harris from Epirus, Inc. a privately held technology company developing software-defined counter-electronics effects and power management solutions for defense and commercial applications, where he most recently served as Chief Executive Officer since 2022 and as President, Chief Operating Officer and Chief Financial Officer from 2020 to 2022. He served as Corporate Vi…read full bio

SOLO BRANDS INC (DTC)
Leaving: CFO – Somer Webb ( 1.6 yrs ; -16.4% TSR)
Replaced by (interim)Andrea K Tarbox
Ms. Tarbox serves on the board of directors of Solo Brands and chairs the audit committee. Ms. Tarbox brings extensive experience in the CFO role. Her 20 years of service in various CFO roles include 12 years at KapStone Paper and Packaging, Inc. (formerly NYSE: KS) where she helped lead KapStone’s successful sale to WestRock Company (NYSE: WRK) in 2018. …read full bio

SYMBOTIC INC (SYM)
Leaving: CFO – Thomas C Ernst Jr ( 1.5 yrs ; 174.1% TSR)
Replaced by: Carol J Hibbard
Ms. Hibbard, age 56, joins the Company from The Boeing Company, a major aerospace firm, where she served as Senior Vice President and Controller since April 2021. Previously, Ms. Hibbard held various strategic and financial roles with The Boeing Company, including Vice President and Chief Financial Officer of Boeing Defense, Space & Security (“BDS”) from May 2017 thr…read full bio

Recent Analysis

CEO & CFO Moves Review – November 8, 2024

Explore last week’s CEO and CFO transitions at major public companies like Adial Pharmaceuticals, Affirm Holdings, Agrify Corp, and Dollar Tree. Learn about the new leaders taking charge amidst financial challenges, governance risks, and stock performance issues. This update covers executive shifts at companies facing shareholder pressures, regulatory scrutiny, and strategic reorganizations.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.